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ABSTRACT
An 18- year old woman with hypertrophic cardiomyopathy, aborted sudden cardiac death and implanted with 
an implantable cardioverter defibrillator (ICD), developed progressive fragmentation of her surface 12-lead 
electrocardiogram (ECG). During the follow-up, she presented with multiple appropriate ICD discharges. Here, 
we discuss the possible association between surface fragmented ECG and the risk of ventricular arrhythmias 
in patients with hypertrophic cardiomyopathy.
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INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a genetically 
heterogeneous heart muscle disorder characterized by 
myocardial hypertrophy in the absence of abnormal loading 
conditions. While it has been recognized for many decades 
that some patients with the disease die suddenly from 
ventricular arrhythmia, data from contemporary studies 
suggest that the annual risk of sudden cardiac death (SCD) 
is in the range of 1%.[1,2] Some risk factors have been shown 
to be associated with an increased risk of SCD in patients 
with HCM.[1] The challenge for clinicians is to identify the 
small cohort of patients who are at a higher risk in order 
to target potentially lifesaving therapy such as implantable 
cardioverter defibrillators (ICD).[2] Fragmented surface 
electrocardiogram (ECG fQRS) has been identified as a 
useful risk marker in other clinical conditions;[3] however, 
its use in arrhythmic events in patients with HCM has not 
been suggested. We report a case of an 18-year-old girl 
with HCM and aborted SCD and implanted with an ICD. 
Her surface 12-lead ECG evolved from normal to fQRS 
complex in less than 7 years. During a 2-year follow-up, 
the ICD delivered several appropriate therapies to the 
malignant ventricular arrhythmias.
CASE REPORT
An 18-year-old female was diagnosed with HCM at the 
age of nine. She presented with recurrent syncope. At that 
time, her 12-lead electrocardiogram (ECG) showed sinus 
rhythm, Q-waves and negative T-waves in leads V5 and V6 
with a QRS duration < 120 ms. [Figure 1, left panel]. Her 
Echocardiogram depicted an asymmetrical left ventricular 
hypertrophy with an interventricular septum measuring 22 
mm and no intraventricular gradient. During the screening, 
secondary causes of left ventricular hypertrophy such as 
systemic hypertension, congenital disease and valvular 
diseases were ruled out. A 24-hour ambulatory Holter 
monitoring showed frequent monomorphic premature 
ventricular contractions. Her first degree relatives were 
screened with ECG and echocardiogram, however, no 
phenotypic HCM was found. The patient remained 
asymptomatic under treatment with atenolol 50 mg/day 
for 7 years, when she suffered a cardiac arrest following 
an episode of emotional stress. Resuscitation was 
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initiated by her mother, and continued by paramedics. 
Ventricular fibrillation (VF) was detected and terminated 
by an external electrical shock. During hospitalization, an 
echocardiogram showed massive left and right ventricular 
hypertrophy with a septal thickness of 38 mm and absence 
of intraventricular gradient [Figure 2]. The surface 12 
lead ECG showed Q-waves in leads I, aVL, V5, V6, left 
ventricular strain pattern, inverted T-waves, and a QRS 
duration of 130 ms with fQRS in all leads. [Figure 1, right 
panel] A dual chamber ICD (Maximo DR 7278, Medtronic, 
Inc, MN, USA) was implanted. The patient was discharged 
and treated with atenolol 50 mg twice a day. During the 
two-year follow-up, the patient presented with sustained 
Ventricular tachycardia (VT) requiring ICD shocks. Anti-
tachycardia pacing was effective in numerous occasions 
Figure 1: In the left panels, 12-lead electrocardiogram (ECG)at the age of nine (2002), depicting sinus rhythm, PR interval 160 ms, QTc 380 
ms and Q-waves in leads V5, V6 with negative T-waves. In the right panel, 12-lead ECG on admission at the age of sixteen (2009), depicting 
sinus rhythm; PR interval 130 ms and delayed left atrial depolarization (the second vector of the P-wave is delayed, most likely by fibrosis of 
the interatrial septum); deep Q-waves in leads I, aVL, V5, and V6, diffuse T-wave inversion, QRS duration 130 ms and different morphologies 
of fQRS, including various RSR´ patterns
to convert VT into a normal sinus rhythm; however, 
on 2 occasions, shocks were necessary to resolve the 
arrhythmia. Atenolol dose was increased and the patient 
has remained asymptomatic since the last six months.
DISCUSSION
SCD is one of the most perplexing issues in the 
management of HMC. The stratification of risk in HCM 
in clinically stable patients is predicated on generally 
accepted noninvasive markers. The accepted risk factors 
in HCM include family history of ≥ 1 HCM-related 
SCDs, ≥ 1 episode of unexplained syncope, massive 
Left ventricular (LV) hypertrophy (thickness ≥ 30 mm); 
nonsustained VT on serial ambulatory 24-hour Holter, 34 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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and hypotensive or attenuated blood pressure response 
to exercise.[1,2] The ECG has traditionally been a part of 
the non-invasive evaluation for patients with HCM and 
though various electrocardiographic abnormalities were 
described, most of them correlated with the magnitude 
and extent of ventricular hypertrophy; however, did not 
reflecte increased risk per se. No specific criterion has 
hitherto been reported to be of value for risk stratification. 
Some investigators have attributed the disturbed 
myocardial electrical properties in HCM to the distinctive 
anatomical substrate of hypertrophied and disorganized 
myocytes.[4] Indeed, ventricular electrogram fractionation 
(delayed myocardial activation) has been documented by 
programmed ventricular extrastimulation in patients with 
HCM and induced VF; however, was absent in patients 
without VF.[4] Recently, Das et al.[3] described the presence 
of fQRS in patients with coronary artery disease (CAD). 
Patients with CAD and fQRS had more cardiovascular 
events and worse prognosis. The fQRS was defined in the 
12-lead ECG as the presence of an additional R-wave (R’) 
or notching in the nadir of the R-wave or the S-wave, or 
the presence of >1 R’ (fragmentation) in 2 contiguous 
leads, corresponding to a major coronary artery territory. 
Fragmented QRS in the presence of wide QRS complexes 
(≥ 120 ms), such as bundle branch block (BBB), premature 
ventricular complexes (PVCs) and paced QRS complexes 
(pQRS), was defined by the presence > 2 notches in the 
R-wave or the S-wave, since BBB already have two notches 
or peaks present in two contiguous leads (3). fQRS has 
been associated with inhomogeneous activation of the 
ventricles due to myocardial scar and/or ischemia, which 
could predict arrhythmic events as well as death.[3] The 
underlying mechanisms of fragmentation have been 
supported by autopsy studies of patients with Myocardial 
infarction (MI) and left ventricular aneurysm. These 
studies showed that the presence of fQRS was associated 
with a significant myocardial necrosis alternating with 
viable myocardial tissue and interspersed in abundant 
fibrous tissue.[3,4] Distribution and pattern of the scar 
depends on the disease states. In CAD, myocardial scars 
are segmental and subendocardial or transmural, whereas 
in nonischemic cardiomyopathy the scars are patchy and 
mid myocardial or subepicardial, predominantly in the 
perivalvular areas.
In the presented case, myocardial scars are probably the 
cause of localized conduction block leading to an additional 
R´ or notching of the R – wave or S - wave. Endocardial 
and epicardial mapping in patients with CAD or dilated 
cardiomyopathy with ventricular arrhythmias have revealed 
fractionated electrograms over a wide area surrounding 
the myocardial scar.[3] fQRS is not specific for CAD, and 
was also observed in other myocardial diseases such as 
dilated cardiomyopathy, some congenital heart diseases, 
arrhythmogenic right ventricular cardiomyopathy and 
Brugada syndrome.[5,6]
To the best of our knowledge, this is the first report of 
a patient with HCM and rapidly progressive fQRS, with 
documented malignant ventricular arrhythmias treated by 
an ICD. The progressive fragmentation of the QRS and 
the presence of malignant ventricular arrhythmias, lead 
us to speculate on the value of fQRS as a predictor of 
ventricular arrhythmias in patients with HCM. Recently, 
Sherrid et al.,[7] in a long series of 330 patients with HCM 
and high-risk criteria of SCD with ICD implantation, 
compared the relationship of electrocardiographic 
findings and appropriate ICD therapies. During a follow-
up of 3.7 ± 3.0 years, 17% of the patients had appropriate 
ICD discharges. The authors found no distinctive ECG 
Figure 2: Parasternal large axis view (left) and apical four-chamber view (right) depicting global thickened of the left ventricular walls and right 
ventricle and interatrial septum involvement. IVS: interventricular septum; LA: left atria; LV: Left ventricle; RA: right atria; RV: right ventricle35 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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characteristics in patients with and without appropriate 
ICD interventions. Bongioanni et al.[8] found in 241 
patients with HCM that a QRS duration ≥ 120 ms had 
an odds ratio of 5.2 for all-cause cardiovascular death; 
however, was not found to predict SCD. Hypothetically, 
the lack of correlation of malignant ventricular 
arrhythmias with ECG abnormalities supports the notion 
that SCD likely depends on transient electrophysiologic 
status and by interacting with the underlying substrate, 
such as vascular ischemia, neuroendocrine or electrolyte 
imbalance. Such transient injuries are consistent with 
the unpredictable nature of HCM-related SCD that 
may occur years after diagnosis, and often without any 
warning. In the presented case, the fQRS probably reflects 
a more severe myocardial disease, manifested by severe 
progression of ventricular hypertrophy. fQRS should be 
investigated in larger series of patients as a possible new 
risk factor and predictor of arrhythmic events in patients 
with HCM.
CONCLUSION
fQRS should be tested in a larger series of patients as a 
possible new risk factor and predictor of arrhythmic events 
in patients with HCM.
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